Literature DB >> 22305022

Cannabis--a valuable drug that deserves better treatment.

Raphael Mechoulam.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22305022      PMCID： PMC3498425          DOI： 10.1016/j.mayocp.2011.12.002

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN： 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  15 in total

Review 1.  Blurred boundaries: the therapeutics and politics of medical marijuana.

Authors:  J Michael Bostwick
Journal:  Mayo Clin Proc       Date:  2012-02       Impact factor: 7.616

Review 2.  Adverse health effects of non-medical cannabis use.

Authors:  Wayne Hall; Louisa Degenhardt
Journal:  Lancet       Date:  2009-10-17       Impact factor: 79.321

3.  The role of cannabinoid receptors in intestinal motility, defaecation and diarrhoea in rats.

Authors:  A A Izzo; N Mascolo; L Pinto; R Capasso; F Capasso
Journal:  Eur J Pharmacol       Date:  1999-11-12       Impact factor: 4.432

4.  Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study.

Authors:  Luc F Van Gaal; Aila M Rissanen; André J Scheen; Olivier Ziegler; Stephan Rössner
Journal:  Lancet       Date:  2005 Apr 16-22       Impact factor: 79.321

5.  Effect of dronabinol on central neuropathic pain after spinal cord injury: a pilot study.

Authors:  Diana H Rintala; Richard Neil Fiess; Gabriel Tan; Sally Ann Holmes; Brian M Bruel
Journal:  Am J Phys Med Rehabil       Date:  2010-10       Impact factor: 2.159

Review 6.  Cannabidiol--recent advances.

Authors:  Raphael Mechoulam; Maximilian Peters; Eric Murillo-Rodriguez; Lumír O Hanus
Journal:  Chem Biodivers       Date:  2007-08       Impact factor: 2.408

7.  Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects.

Authors:  A W Zuardi; I Shirakawa; E Finkelfarb; I G Karniol
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

8.  Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial.

Authors:  F Xavier Pi-Sunyer; Louis J Aronne; Hassan M Heshmati; Jeanne Devin; Julio Rosenstock
Journal:  JAMA       Date:  2006-02-15       Impact factor: 56.272

Review 9.  Tetrahydrocannabinol and endocannabinoids in feeding and appetite.

Authors:  Elliot M Berry; Raphael Mechoulam
Journal:  Pharmacol Ther       Date:  2002-08       Impact factor: 12.310

10.  An efficient new cannabinoid antiemetic in pediatric oncology.

Authors:  A Abrahamov; A Abrahamov; R Mechoulam
Journal:  Life Sci       Date:  1995       Impact factor: 5.037
View more
  4 in total

1.  Complementary and alternative medicine in multiple sclerosis: Payment policy perspectives.

Authors:  Heidi Moawad; Katie M Shepard; Saty Satya-Murti
Journal:  Neurol Clin Pract       Date:  2015-02

2.  Effect of the synthetic cannabinoid HU-210 on quorum sensing and on the production of quorum sensing-mediated virulence factors by Vibrio harveyi.

Authors:  Divya Soni; Reem Smoum; Aviva Breuer; Raphael Mechoulam; Doron Steinberg
Journal:  BMC Microbiol       Date:  2015-08-12       Impact factor: 3.605

Review 3.  Endocannabinoid signaling in social functioning: an RDoC perspective.

Authors:  D S Karhson; A Y Hardan; K J Parker
Journal:  Transl Psychiatry       Date:  2016-09-27       Impact factor: 6.222

4.  Benefit of Tetrahydrocannabinol versus Cannabidiol for Common Palliative Care Symptoms.

Authors:  David J Casarett; Jessica N Beliveau; Michelle S Arbus
Journal:  J Palliat Med       Date:  2019-08-06       Impact factor: 2.947
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.